Report Detail
Global Granulocyte-Colony Stimulating Factor Market Professional Survey Report 2019
- RnM3772921 |
- 23 September, 2019 |
- Global |
- 109 Pages |
- QYResearch |
- Pharma & Healthcare
Granulocyte-colony stimulating factor (G-CSF or GCSF), also known as colony-stimulating factor 3 (CSF 3), is a glycoprotein that stimulates the bone marrow to produce granulocytes and stem cellsand release them into the bloodstream.
Functionally, it is a cytokine and hormone, a type of colony-stimulating factor, and is produced by a number of different tissues.
The pharmaceutical analogs of naturally occurring G-CSF are called filgrastim and lenograstim.
G-CSF also stimulates the survival, proliferation, differentiation, and function of neutrophil precursors and mature neutrophils.
The global Granulocyte-Colony Stimulating Factor market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Granulocyte-Colony Stimulating Factor volume and value at global level, regional level and company level. From a global perspective, this report represents overall Granulocyte-Colony Stimulating Factor market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Granulocyte-Colony Stimulating Factor in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Granulocyte-Colony Stimulating Factor manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
BioCad
Dong-A Socio Group
Pfizer
Intas Pharmaceuticals
Novartis AG
Stada Arzneimittel
Teva Pharmaceutical Industries
Amgen
Dr. Reddy's Laboratories
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
Capsules
Tablets
Others
Segment by Application
Oncological Diseases
Blood Disorders
Growth Hormone Deficiencies
Chronic and Autoimmune Disorders
Others
Table of Contents
Executive Summary
1 Industry Overview of Granulocyte-Colony Stimulating Factor
- 1.1 Definition of Granulocyte-Colony Stimulating Factor
- 1.2 Granulocyte-Colony Stimulating Factor Segment by Type
- 1.2.1 Global Granulocyte-Colony Stimulating Factor Production Growth Rate Comparison by Types (2014-2025)
- 1.2.2 Capsules
- 1.2.3 Tablets
- 1.2.4 Others
- 1.3 Granulocyte-Colony Stimulating Factor Segment by Applications
- 1.3.1 Global Granulocyte-Colony Stimulating Factor Consumption Comparison by Applications (2014-2025)
- 1.3.2 Oncological Diseases
- 1.3.3 Blood Disorders
- 1.3.4 Growth Hormone Deficiencies
- 1.3.5 Chronic and Autoimmune Disorders
- 1.3.6 Others
- 1.4 Global Granulocyte-Colony Stimulating Factor Overall Market
- 1.4.1 Global Granulocyte-Colony Stimulating Factor Revenue (2014-2025)
- 1.4.2 Global Granulocyte-Colony Stimulating Factor Production (2014-2025)
- 1.4.3 North America Granulocyte-Colony Stimulating Factor Status and Prospect (2014-2025)
- 1.4.4 Europe Granulocyte-Colony Stimulating Factor Status and Prospect (2014-2025)
- 1.4.5 China Granulocyte-Colony Stimulating Factor Status and Prospect (2014-2025)
- 1.4.6 Japan Granulocyte-Colony Stimulating Factor Status and Prospect (2014-2025)
- 1.4.7 Southeast Asia Granulocyte-Colony Stimulating Factor Status and Prospect (2014-2025)
- 1.4.8 India Granulocyte-Colony Stimulating Factor Status and Prospect (2014-2025)
2 Manufacturing Cost Structure Analysis
- 2.1 Raw Material and Suppliers
- 2.2 Manufacturing Cost Structure Analysis of Granulocyte-Colony Stimulating Factor
- 2.3 Manufacturing Process Analysis of Granulocyte-Colony Stimulating Factor
- 2.4 Industry Chain Structure of Granulocyte-Colony Stimulating Factor
3 Development and Manufacturing Plants Analysis of Granulocyte-Colony Stimulating Factor
- 3.1 Capacity and Commercial Production Date
- 3.2 Global Granulocyte-Colony Stimulating Factor Manufacturing Plants Distribution
- 3.3 Major Manufacturers Technology Source and Market Position of Granulocyte-Colony Stimulating Factor
- 3.4 Recent Development and Expansion Plans
4 Key Figures of Major Manufacturers
- 4.1 Granulocyte-Colony Stimulating Factor Production and Capacity Analysis
- 4.2 Granulocyte-Colony Stimulating Factor Revenue Analysis
- 4.3 Granulocyte-Colony Stimulating Factor Price Analysis
- 4.4 Market Concentration Degree
5 Granulocyte-Colony Stimulating Factor Regional Market Analysis
- 5.1 Granulocyte-Colony Stimulating Factor Production by Regions
- 5.1.1 Global Granulocyte-Colony Stimulating Factor Production by Regions
- 5.1.2 Global Granulocyte-Colony Stimulating Factor Revenue by Regions
- 5.2 Granulocyte-Colony Stimulating Factor Consumption by Regions
- 5.3 North America Granulocyte-Colony Stimulating Factor Market Analysis
- 5.3.1 North America Granulocyte-Colony Stimulating Factor Production
- 5.3.2 North America Granulocyte-Colony Stimulating Factor Revenue
- 5.3.3 Key Manufacturers in North America
- 5.3.4 North America Granulocyte-Colony Stimulating Factor Import and Export
- 5.4 Europe Granulocyte-Colony Stimulating Factor Market Analysis
- 5.4.1 Europe Granulocyte-Colony Stimulating Factor Production
- 5.4.2 Europe Granulocyte-Colony Stimulating Factor Revenue
- 5.4.3 Key Manufacturers in Europe
- 5.4.4 Europe Granulocyte-Colony Stimulating Factor Import and Export
- 5.5 China Granulocyte-Colony Stimulating Factor Market Analysis
- 5.5.1 China Granulocyte-Colony Stimulating Factor Production
- 5.5.2 China Granulocyte-Colony Stimulating Factor Revenue
- 5.5.3 Key Manufacturers in China
- 5.5.4 China Granulocyte-Colony Stimulating Factor Import and Export
- 5.6 Japan Granulocyte-Colony Stimulating Factor Market Analysis
- 5.6.1 Japan Granulocyte-Colony Stimulating Factor Production
- 5.6.2 Japan Granulocyte-Colony Stimulating Factor Revenue
- 5.6.3 Key Manufacturers in Japan
- 5.6.4 Japan Granulocyte-Colony Stimulating Factor Import and Export
- 5.7 Southeast Asia Granulocyte-Colony Stimulating Factor Market Analysis
- 5.7.1 Southeast Asia Granulocyte-Colony Stimulating Factor Production
- 5.7.2 Southeast Asia Granulocyte-Colony Stimulating Factor Revenue
- 5.7.3 Key Manufacturers in Southeast Asia
- 5.7.4 Southeast Asia Granulocyte-Colony Stimulating Factor Import and Export
- 5.8 India Granulocyte-Colony Stimulating Factor Market Analysis
- 5.8.1 India Granulocyte-Colony Stimulating Factor Production
- 5.8.2 India Granulocyte-Colony Stimulating Factor Revenue
- 5.8.3 Key Manufacturers in India
- 5.8.4 India Granulocyte-Colony Stimulating Factor Import and Export
6 Granulocyte-Colony Stimulating Factor Segment Market Analysis (by Type)
- 6.1 Global Granulocyte-Colony Stimulating Factor Production by Type
- 6.2 Global Granulocyte-Colony Stimulating Factor Revenue by Type
- 6.3 Granulocyte-Colony Stimulating Factor Price by Type
7 Granulocyte-Colony Stimulating Factor Segment Market Analysis (by Application)
- 7.1 Global Granulocyte-Colony Stimulating Factor Consumption by Application
- 7.2 Global Granulocyte-Colony Stimulating Factor Consumption Market Share by Application (2014-2019)
8 Granulocyte-Colony Stimulating Factor Major Manufacturers Analysis
- 8.1 BioCad
- 8.1.1 BioCad Granulocyte-Colony Stimulating Factor Production Sites and Area Served
- 8.1.2 BioCad Product Introduction, Application and Specification
- 8.1.3 BioCad Granulocyte-Colony Stimulating Factor Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.1.4 Main Business and Markets Served
- 8.2 Dong-A Socio Group
- 8.2.1 Dong-A Socio Group Granulocyte-Colony Stimulating Factor Production Sites and Area Served
- 8.2.2 Dong-A Socio Group Product Introduction, Application and Specification
- 8.2.3 Dong-A Socio Group Granulocyte-Colony Stimulating Factor Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.2.4 Main Business and Markets Served
- 8.3 Pfizer
- 8.3.1 Pfizer Granulocyte-Colony Stimulating Factor Production Sites and Area Served
- 8.3.2 Pfizer Product Introduction, Application and Specification
- 8.3.3 Pfizer Granulocyte-Colony Stimulating Factor Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.3.4 Main Business and Markets Served
- 8.4 Intas Pharmaceuticals
- 8.4.1 Intas Pharmaceuticals Granulocyte-Colony Stimulating Factor Production Sites and Area Served
- 8.4.2 Intas Pharmaceuticals Product Introduction, Application and Specification
- 8.4.3 Intas Pharmaceuticals Granulocyte-Colony Stimulating Factor Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.4.4 Main Business and Markets Served
- 8.5 Novartis AG
- 8.5.1 Novartis AG Granulocyte-Colony Stimulating Factor Production Sites and Area Served
- 8.5.2 Novartis AG Product Introduction, Application and Specification
- 8.5.3 Novartis AG Granulocyte-Colony Stimulating Factor Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.5.4 Main Business and Markets Served
- 8.6 Stada Arzneimittel
- 8.6.1 Stada Arzneimittel Granulocyte-Colony Stimulating Factor Production Sites and Area Served
- 8.6.2 Stada Arzneimittel Product Introduction, Application and Specification
- 8.6.3 Stada Arzneimittel Granulocyte-Colony Stimulating Factor Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.6.4 Main Business and Markets Served
- 8.7 Teva Pharmaceutical Industries
- 8.7.1 Teva Pharmaceutical Industries Granulocyte-Colony Stimulating Factor Production Sites and Area Served
- 8.7.2 Teva Pharmaceutical Industries Product Introduction, Application and Specification
- 8.7.3 Teva Pharmaceutical Industries Granulocyte-Colony Stimulating Factor Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.7.4 Main Business and Markets Served
- 8.8 Amgen
- 8.8.1 Amgen Granulocyte-Colony Stimulating Factor Production Sites and Area Served
- 8.8.2 Amgen Product Introduction, Application and Specification
- 8.8.3 Amgen Granulocyte-Colony Stimulating Factor Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.8.4 Main Business and Markets Served
- 8.9 Dr. Reddy's Laboratories
- 8.9.1 Dr. Reddy's Laboratories Granulocyte-Colony Stimulating Factor Production Sites and Area Served
- 8.9.2 Dr. Reddy's Laboratories Product Introduction, Application and Specification
- 8.9.3 Dr. Reddy's Laboratories Granulocyte-Colony Stimulating Factor Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.9.4 Main Business and Markets Served
9 Development Trend of Analysis of Granulocyte-Colony Stimulating Factor Market
- 9.1 Global Granulocyte-Colony Stimulating Factor Market Trend Analysis
- 9.1.1 Global Granulocyte-Colony Stimulating Factor Market Size (Volume and Value) Forecast 2019-2025
- 9.2 Granulocyte-Colony Stimulating Factor Regional Market Trend
- 9.2.1 North America Granulocyte-Colony Stimulating Factor Forecast 2019-2025
- 9.2.2 Europe Granulocyte-Colony Stimulating Factor Forecast 2019-2025
- 9.2.3 China Granulocyte-Colony Stimulating Factor Forecast 2019-2025
- 9.2.4 Japan Granulocyte-Colony Stimulating Factor Forecast 2019-2025
- 9.2.5 Southeast Asia Granulocyte-Colony Stimulating Factor Forecast 2019-2025
- 9.2.6 India Granulocyte-Colony Stimulating Factor Forecast 2019-2025
- 9.3 Granulocyte-Colony Stimulating Factor Market Trend (Product Type)
- 9.4 Granulocyte-Colony Stimulating Factor Market Trend (Application)
- 10.1 Marketing Channel
- 10.1.1 Direct Marketing
- 10.1.2 Indirect Marketing
- 10.3 Granulocyte-Colony Stimulating Factor Customers
11 Market Dynamics
- 11.1 Market Trends
- 11.2 Opportunities
- 11.3 Market Drivers
- 11.4 Challenges
- 11.5 Influence Factors
12 Conclusion
13 Appendix
- 13.1 Methodology/Research Approach
- 13.1.1 Research Programs/Design
- 13.1.2 Market Size Estimation
- 13.1.3 Market Breakdown and Data Triangulation
- 13.2 Data Source
- 13.2.1 Secondary Sources
- 13.2.2 Primary Sources
- 13.3 Author List
Summary:
Get latest Market Research Reports on Granulocyte-Colony Stimulating Factor. Industry analysis & Market Report on Granulocyte-Colony Stimulating Factor is a syndicated market report, published as Global Granulocyte-Colony Stimulating Factor Market Professional Survey Report 2019. It is complete Research Study and Industry Analysis of Granulocyte-Colony Stimulating Factor market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
